Because 20 years ago the cells required couldn't be exactly reproduced which is required for FDA approval
That process is now possible.
That's why the treatment was shelved 20 years ago waiting for cGMP cell production to catch up.
It was a therapy ahead of its time
It's time has now come and master and working banks are currently being produced and verified for our pivotal trial which is expected in fourth quarter as agreed by the FDA in the pre ind meeting with pharmacyte.
Market Data 
Markets 
AI
